Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies - 15/02/21
Authors Olamiju and Bhullar contributed equally to this article. |
|
Funding sources: None. |
|
Conflicts of interest: None disclosed. |
|
IRB approval status: Reviewed and approved by Yale University School of Medicine (approval no. 2000027841). |
Vol 84 - N° 3
P. 806-808 - mars 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?